Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pralatrexate (PDX) in Advanced Non-Small Cell Lung Cancer
NCT00004238Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 1999
- Primary completion
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pralatrexate in non-small cell lung cancer (NSCLC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jul 1999; status: completed.
02
Drugs
pralatrexate
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00004238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004238.